A collaborative study by researchers from Baylor College of Medicine and Illumina has showcased the exceptional capabilities of the DRAGEN (Dynamic Read Analysis for GENomics) platform in comprehensive genome analysis.
Validation testing of next-gen genome analysis platform reveals potentially disruptive tech
Posted in biotech/medical